Breast Cancer
Breast cancer treatment between-surgeon variation reduced by broader dissemination of guidelines
Published in Clinical Oncology Week, September 11th, 2006
According to recent research from the United States, "Determinants of between-surgeon variation in breast cancer treatment utilization are not well understood. The objectives of this study were to evaluate variation in receipt of surgical treatment (ie, mastectomy or breast-conserving surgery with or without radiation) for women with stage I, II, or III breast cancer and receipt of breast reconstruction attributable to surgeons, and to assess factors associated with this between-surgeon...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Complementary & Alternative Medicine
Acupuncture and acupressure helped reduce chemotherapy-induced nausea - Gynecology
Carcinomas of the female genital tract developed after pelvic irradiation - Head & Neck Cancer
Head and neck cancer receives alternative regimen in docetaxel chemoradiotherapy - Lung Cancer
Lung cancer quality of life better maintained by docetaxel/carboplatin regimen - Skin Cancer
Facial basal cell carcinoma treated by use of 5% imiquimod cream - Acute Lymphoblastic Leukemia
Hana initiates Marqibo phase II trial in relapsed or refractory acute lymphoblastic leukemia - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
